Li B, Ming H, Qin S, Nice E, Dong J, Du Z
Signal Transduct Target Ther. 2025; 10(1):72.
PMID: 40050273
PMC: 11885647.
DOI: 10.1038/s41392-024-02095-6.
Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y
Mol Cancer. 2024; 23(1):261.
PMID: 39574178
PMC: 11580516.
DOI: 10.1186/s12943-024-02165-x.
Ramirez I, Sadak O, Sohail W, Huang X, Lu Y, Iverson N
Carbon Lett (Korean Carbon Soc). 2024; 34(5):1343-1354.
PMID: 39015541
PMC: 11250639.
DOI: 10.1007/s42823-024-00691-8.
Kim M, Park S, Lee D
Cancers (Basel). 2021; 13(22).
PMID: 34830916
PMC: 8616433.
DOI: 10.3390/cancers13225762.
Huang H, Li S, Tang Q, Zhu G
Front Immunol. 2021; 12:680955.
PMID: 34566954
PMC: 8458828.
DOI: 10.3389/fimmu.2021.680955.
Interplay Among Hydrogen Sulfide, Nitric Oxide, Reactive Oxygen Species, and Mitochondrial DNA Oxidative Damage.
Huang D, Jing G, Zhang L, Chen C, Zhu S
Front Plant Sci. 2021; 12:701681.
PMID: 34421950
PMC: 8377586.
DOI: 10.3389/fpls.2021.701681.
iNOS Associates With Poor Survival in Melanoma: A Role for Nitric Oxide in the PI3K-AKT Pathway Stimulation and PTEN S-Nitrosylation.
Ding Z, Ogata D, Roszik J, Qin Y, Kim S, Tetzlaff M
Front Oncol. 2021; 11:631766.
PMID: 33643925
PMC: 7907506.
DOI: 10.3389/fonc.2021.631766.
Quantification of Nitric Oxide Concentration Using Single-Walled Carbon Nanotube Sensors.
Meier J, Stapleton J, Hofferber E, Haworth A, Kachman S, Iverson N
Nanomaterials (Basel). 2021; 11(1).
PMID: 33477618
PMC: 7831316.
DOI: 10.3390/nano11010243.
The Role of Nitric Oxide in Cancer: Master Regulator or NOt?.
Khan F, Dervan E, Bhattacharyya D, McAuliffe J, Miranda K, Glynn S
Int J Mol Sci. 2020; 21(24).
PMID: 33321789
PMC: 7763974.
DOI: 10.3390/ijms21249393.
Role of Melanin Chemiexcitation in Melanoma Progression and Drug Resistance.
Premi S
Front Oncol. 2020; 10:1305.
PMID: 32850409
PMC: 7425655.
DOI: 10.3389/fonc.2020.01305.
Nitric oxide: Friend or Foe in Cancer Chemotherapy and Drug Resistance: A Perspective.
Sinha B
J Cancer Sci Ther. 2019; 8:244-251.
PMID: 31844487
PMC: 6914264.
DOI: 10.4172/1948-5956.1000421.
S-Nitrosylation: An Emerging Paradigm of Redox Signaling.
Fernando V, Zheng X, Walia Y, Sharma V, Letson J, Furuta S
Antioxidants (Basel). 2019; 8(9).
PMID: 31533268
PMC: 6769533.
DOI: 10.3390/antiox8090404.
A new perspective on oxidation of DNA repair proteins and cancer.
Alnajjar K, Sweasy J
DNA Repair (Amst). 2019; 76:60-69.
PMID: 30818170
PMC: 6419097.
DOI: 10.1016/j.dnarep.2019.02.006.
Nitric oxide inhibits ATPase activity and induces resistance to topoisomerase II-poisons in human MCF-7 breast tumor cells.
Sinha B, Kumar A, Mason R
Biochem Biophys Rep. 2017; 10:252-259.
PMID: 28955753
PMC: 5614683.
DOI: 10.1016/j.bbrep.2017.04.011.
The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer.
Sishc B, Davis A
Cancers (Basel). 2017; 9(7).
PMID: 28684677
PMC: 5532617.
DOI: 10.3390/cancers9070081.
Exogenous Nitric Oxide Suppresses in Vivo X-ray-Induced Targeted and Non-Targeted Effects in Zebrafish Embryos.
Kong E, Yeung W, Chan T, Cheng S, Yu K
Int J Mol Sci. 2016; 17(8).
PMID: 27529238
PMC: 5000718.
DOI: 10.3390/ijms17081321.
Nitric oxide inhibits topoisomerase II activity and induces resistance to topoisomerase II-poisons in human tumor cells.
Kumar A, Ehrenshaft M, Tokar E, Mason R, Sinha B
Biochim Biophys Acta. 2016; 1860(7):1519-27.
PMID: 27095671
PMC: 4909546.
DOI: 10.1016/j.bbagen.2016.04.009.
Significance of twist and iNOS expression in human breast carcinoma.
Ranganathan S, Krishnan A, Sivasithambaram N
Mol Cell Biochem. 2015; 412(1-2):41-7.
PMID: 26590086
DOI: 10.1007/s11010-015-2606-9.
Nitric Oxide Down-Regulates Topoisomerase I and Induces Camptothecin Resistance in Human Breast MCF-7 Tumor Cells.
Sharma N, Kumar A, Kumari A, Tokar E, Waalkes M, Bortner C
PLoS One. 2015; 10(11):e0141897.
PMID: 26540186
PMC: 4635000.
DOI: 10.1371/journal.pone.0141897.
The dual role of iNOS in cancer.
Vannini F, Kashfi K, Nath N
Redox Biol. 2015; 6:334-343.
PMID: 26335399
PMC: 4565017.
DOI: 10.1016/j.redox.2015.08.009.